Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular effects of lithium.

Jorge A Quiroz1, Todd D Gould, Husseini K Manji

  • 1Laboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, National Institute of Mental Health, NIH, Bethesda, Maryland 20892, USA.

Molecular Interventions
|October 9, 2004
PubMed
Summary

Lithium, a treatment for bipolar disorder, impacts key enzymes and signaling pathways. New research explores its potential for neurodegenerative diseases by understanding these molecular actions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology.

Journal of psychopharmacology (Oxford, England)·2026
Same author

Design, simulate, refine: simulation-guided clinical trials for accelerated drug development.

Nature reviews. Drug discovery·2026
Same author

Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition.

The Journal of clinical investigation·2026
Same author

The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review.

JAMA psychiatry·2026
Same author

A Time-Sensitive Plasticity Distinguishes the Rapid and Sustained Synaptic Actions of Ketamine from Its (2<i>R</i>,6<i>R</i>)-Hydroxynorketamine Metabolite.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Implementing Precision Medicine in Psychiatry.

JAMA psychiatry·2025

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Bipolar disorder is a severe, chronic psychiatric illness often presenting with comorbidities.
  • Lithium revolutionized bipolar disorder treatment over 50 years ago.
  • Recent research reveals novel molecular targets for lithium.

Purpose of the Study:

  • To review recent insights into lithium's molecular actions.
  • To discuss lithium's potential therapeutic applications beyond bipolar disorder, including neurodegenerative diseases.
  • To highlight how understanding lithium's mechanisms can inform future drug development.

Main Methods:

  • Review of molecular and cellular biological studies on lithium.
  • Analysis of lithium's direct inhibitory actions on specific enzymes.
  • Discussion of lithium's intracellular downstream targets and signaling cascades.

Main Results:

  • Lithium directly inhibits enzymes such as glycogen synthase kinase-3 (GSK-3) and inositol monophosphatase.
  • Lithium affects intracellular pathways including the phosphoinositol cascade, protein kinase C, and neurotrophic signaling.
  • These actions suggest a reconceptualization of bipolar disorder's biological basis.

Conclusions:

  • Lithium's diverse molecular targets provide a deeper understanding of its therapeutic effects in bipolar disorder.
  • Emerging evidence supports investigating lithium for neurodegenerative disorders.
  • Further research into lithium's mechanisms may lead to improved therapeutics for psychiatric and neurological conditions.

Related Experiment Videos